Feasibility of a Yoga Intervention in Sedentary African-American Women
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04710979 |
Recruitment Status :
Recruiting
First Posted : January 15, 2021
Last Update Posted : November 30, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Sedentary Behavior | Behavioral: Yoga Intervention | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Prevention |
Official Title: | Feasibility of a Yoga Intervention in Sedentary African-American Women |
Actual Study Start Date : | September 30, 2021 |
Estimated Primary Completion Date : | October 1, 2022 |
Estimated Study Completion Date : | August 31, 2023 |

Arm | Intervention/treatment |
---|---|
Experimental: Yoga Intervention Group |
Behavioral: Yoga Intervention
This group will have in-person, 60 minute yoga sessions three times per week for 12 weeks. These sessions will also include a sharing circle to provide group feedback as to how the practice felt and integration into ones' daily life. There will be biweekly themes established for these sessions (i.e. common yoga poses, importance of breath) and biweekly in-person workshops will be offered. These will be specialty classes for participants to experience additional exposure to meditation and breathing. They will be a longer format so participants can delve deeper into yogic philosophy and practice. There will also be a private Facebook group for participants to connect with each other and for the research staff to maintain contact and share information with the participants (eg. weekly reminder for yoga sessions and workshops). |
No Intervention: Control Group
Control participants will receive no guidance from the research staff to change their behavior.
|
- Number of Participants Recruited (Feasibility) [ Time Frame: Baseline ]200 women recruited and screened; 76 women (60 for pilot intervention) enrolled and consented
- Rate of Participant Retention and Adherence (Feasibility) [ Time Frame: Post-intervention (within 2 months) ]At least 80% of intervention participants attend at least 80% of intervention sessions
- Fidelity of Intervention Delivery (Feasibility) [ Time Frame: Post-intervention (within 2 months) ]At least 90% of each videotaped session is delivered as planned based on training
- Rate of Delivery of Intervention Materials and Resources (Feasibility) [ Time Frame: Post-intervention (within 2 months) ]100% of intervention materials and resources are delivered as planned
- Rating and Completion of Assessment Measures (Feasibility) [ Time Frame: Baseline ]At least 80% intervention and control participants rate the assessments as not too burdensome; at least 90% intervention and control participants will complete baseline assessments
- Rating and Completion of Assessment Measures (Feasibility) [ Time Frame: Post-intervention (within 2 months) ]At least 80% intervention and control participants rate the assessments as not too burdensome; at least 90% intervention and control participants will complete post-intervention assessments
- Rating and Completion of Assessment Measures (Feasibility) [ Time Frame: 3-month follow-up ]At least 80% intervention and control participants rate the assessments as not too burdensome; at least 90% intervention and control participants will complete 3-month follow-up assessments
- Rating of Intervention Location, in-person classes, instructors, home-based resources (Acceptability) [ Time Frame: Post-intervention (within 2 months) ]At least 90% intervention participants rate the various intervention components as acceptable
- Participant Rating of Yoga Intervention (Acceptability) [ Time Frame: Post-intervention (within 2 months) ]At least 90% intervention participants rate intervention acceptable
- Number of Adverse Events (Safety) [ Time Frame: Post-intervention (within 2 months) ]Zero adverse events (causes major disruption to participants' life, e.g., sprain, broken bone, cardiovascular event, death), zero moderate adverse events (causes minor inconvenience to participant, e.g., fainting spell, sore muscles for more than 3 days) and less than 10% of participants report mild adverse events (no major impact, e.g., headache, sore muscles for 2-3 days)
- Sedentary behavior [ Time Frame: Seven consecutive days at baseline before intervention, during three randomly selected weeks over the course of the 3-month intervention, for one week at post-intervention, and one week at 3-month follow-up periods ]Assessed with activPAL3 micro accelerometer
- Systolic and Diastolic Blood pressure [ Time Frame: Two blood pressures will be collected and averaged at each data collection time point (baseline, one month post-intervention window, and 3 month follow-up) ]Measured using BpTRU BPM-200
- Salivary Cortisol Levels [ Time Frame: 3 times per day (upon waking, 30 minutes after waking, before going to bed) for 2 days at each data collection timepoint (baseline, one month post-intervention window, and 3 month follow-up) ]Biomarkers of physiological stress using cortisol saliva (nmol/L)
- Perceived Stress [ Time Frame: Questionnaires will be distributed at each data collection timepoint (baseline, one month post-intervention window, and 3 month follow-up) ]Measured using the Perceived Stress Scale (higher scores indicate higher perceived stress)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Self-identified as an African-American woman at least 18 years old
- Engaging in less than 30 minutes/week of moderate-to-vigorous physical activity
- If employed, working in a sedentary occupation that requires primarily seated work; • If unemployed, typical day involves sedentary, primarily seated activities
- Able to exercise for 20 minutes continuously
- No pre-existing condition that limits physical activity
- Access to a computer (or mobile device) and internet service
Exclusion Criteria:
- Diagnosed with heart disease, diabetes, cancer, kidney, liver disease, major depression or bipolar disease
- Take more than two daily medications for lipids or blood pressure
- Current smoker

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04710979
Contact: Daheia J Barr-Anderson, PhD | 2404752806 | barra027@umn.edu | |
Contact: Mark A Pereira, PhD | 6126244173 | perei004@umn.edu |
United States, Minnesota | |
University of Minnesota | Recruiting |
Minneapolis, Minnesota, United States, 55455 | |
Contact: Daheia Julina Barranderson, PhD, MSPH | |
Principal Investigator: Daheia Julina Barranderson, PhD, MSPH |
Responsible Party: | University of Minnesota |
ClinicalTrials.gov Identifier: | NCT04710979 |
Other Study ID Numbers: |
STUDY00010979 R34AT011036 ( U.S. NIH Grant/Contract ) |
First Posted: | January 15, 2021 Key Record Dates |
Last Update Posted: | November 30, 2021 |
Last Verified: | November 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Yoga African-American Feasibility Study |